Skip to main content

Advertisement

ADVERTISEMENT

Insights

Headshots
Videos
09/13/2023

Featuring Daniel Sontupe, Todd Prewitt, MD, and Yash Prajapati

Featuring Daniel Sontupe, Todd Prewit...
In this roundtable, Daniel Sontupe, managing director, The Bloc Value Builders, moderates a conversation with Todd Prewitt, MD, corporate medical director, value-based health strategies, Humana, and Yash Prajapati, consultant, ZS, about...
In this roundtable, Daniel Sontupe, managing director, The Bloc Value Builders, moderates a conversation with Todd Prewitt, MD, corporate medical director, value-based health strategies, Humana, and Yash Prajapati, consultant, ZS, about...
In this roundtable, Daniel...
09/13/2023
First Report Managed Care
Headshot of Courtney Quinn, Navitus Health Solutions
Interview
04/13/2023
Maria Asimopoulos
Courtney Quinn, PharmD, PGY1 pharmacy resident, Navitus Health Solutions, examined potential cost saving trends if individuals enrolled in 4 large commercial health plans switched from reference product insulin glargine to biosimilars.
Courtney Quinn, PharmD, PGY1 pharmacy resident, Navitus Health Solutions, examined potential cost saving trends if individuals enrolled in 4 large commercial health plans switched from reference product insulin glargine to biosimilars.
Courtney Quinn, PharmD, PGY1...
04/13/2023
First Report Managed Care
Headshot of Ann Latner, JD
Commentary
01/17/2023
Ann W Latner, JD
Ann Latner shares details from a complaint which alleged several drug manufacturers and pharmacy benefit managers raised the prices of insulin in violation of Kansas's Consumer Protection Act.
Ann Latner shares details from a complaint which alleged several drug manufacturers and pharmacy benefit managers raised the prices of insulin in violation of Kansas's Consumer Protection Act.
Ann Latner shares details from a...
01/17/2023
Pharmacy Learning Network

Advertisement

Headshot of German Hernandez, fellow of the American Society of Nephrology
Commentary
11/18/2021

German Hernandez, MD, FASN contributor

German Hernandez, MD, FASN contributo...
German Hernandez, MD, provides nutrition tips for patients living with autosomal dominant polycystic kidney disease and stresses that “incorporating them into a patient’s routine as soon as diagnosis is confirmed may make a difference in...
German Hernandez, MD, provides nutrition tips for patients living with autosomal dominant polycystic kidney disease and stresses that “incorporating them into a patient’s routine as soon as diagnosis is confirmed may make a difference in...
German Hernandez, MD, provides...
11/18/2021
First Report Managed Care
Improved Reimbursement Options Needed for National Diabetes Prevention Program Providers
Interview
03/17/2020
Jennifer Torres Mosst, PhD, program manager of Diabetes Strategies at the Division of Chronic Disease and Injury Prevention, explain why billing and reimbursement approaches play a critical role in the types of programs that can be...
Jennifer Torres Mosst, PhD, program manager of Diabetes Strategies at the Division of Chronic Disease and Injury Prevention, explain why billing and reimbursement approaches play a critical role in the types of programs that can be...
Jennifer Torres Mosst, PhD,...
03/17/2020
First Report Managed Care
Among Diabetes Patients, Cost Increases Linked With Guideline Non-Compliance
Interview
03/10/2020
Swapnil Rajpathak, executive director cardiometabolic team, Center for Observational Real World Evidence, Merck & Co, Inc, discusses the importance of adherence to evidence-based care guidelines to improve health outcomes and reduce costs.
Swapnil Rajpathak, executive director cardiometabolic team, Center for Observational Real World Evidence, Merck & Co, Inc, discusses the importance of adherence to evidence-based care guidelines to improve health outcomes and reduce costs.
Swapnil Rajpathak, executive...
03/10/2020
First Report Managed Care

Advertisement

Interview
07/09/2019
Kiersten Combs, vice president of US Cardiovascular & Metabolic Disease, and Jim McDermott, vice president of US Medical Affairs and Metabolism, both at AstraZeneca, highlight how the use of Farxiga and other SGLT2 inhibitors impact payers...
Kiersten Combs, vice president of US Cardiovascular & Metabolic Disease, and Jim McDermott, vice president of US Medical Affairs and Metabolism, both at AstraZeneca, highlight how the use of Farxiga and other SGLT2 inhibitors impact payers...
Kiersten Combs, vice president...
07/09/2019
First Report Managed Care
Interview
04/17/2019
Christina Nguyen, senior research analyst, and Mary Beth Landrum, PhD, professor of health care policy, both at Harvard Medical School, explain why inadequate risk adjustment could counterproductively reduce payments to groups whose patient...
Christina Nguyen, senior research analyst, and Mary Beth Landrum, PhD, professor of health care policy, both at Harvard Medical School, explain why inadequate risk adjustment could counterproductively reduce payments to groups whose patient...
Christina Nguyen, senior...
04/17/2019
First Report Managed Care

Advertisement